human | Q5 |
P496 | ORCID iD | 0000-0001-6611-8050 |
P1153 | Scopus author ID | 8248241400 |
P735 | given name | María | Q18088640 |
María | Q18088640 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q28301079 | Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization |
Q44342677 | Brain-specific Galphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway. |
Q34713973 | Calcium/calmodulin-dependent protein kinase II supports morphine antinociceptive tolerance by phosphorylation of glycosylated phosducin-like protein. |
Q42872711 | Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. |
Q44347620 | Detecting zinc release induced by mu-opioid receptor agonists in brain slices |
Q38037679 | Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. |
Q28245135 | Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS |
Q44938371 | Expression of neural RGS-R7 and Gbeta5 Proteins in Response to Acute and Chronic Morphine. |
Q48685376 | GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein. |
Q37364657 | HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity |
Q21223665 | Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins |
Q33619345 | Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling |
Q44339601 | NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. |
Q41879563 | NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor. |
Q38105951 | Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. |
Q28299855 | RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits |
Q34682536 | RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. |
Q43440389 | RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway. |
Q34097919 | SUMO-SIM interactions regulate the activity of RGSZ2 proteins |
Q44331639 | Sumoylated RGS-Rz proteins act as scaffolds for Mu-opioid receptors and G-protein complexes in mouse brain. |
Q28565519 | Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits |
Q44341937 | The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects. |
Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
Q44348688 | The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation |
Q38090227 | The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain. |
Q43195386 | The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control |
Search more.